Project Grant R50CA305048
Award Date 9/4/25
Completion Date 8/31/30
Dollars Obligated $136K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Kansas City, KS 66160, USA
Similar Awards
- The University of Kansas Medical Center Research Institute, Inc. was awarded a $135,949 Project Grant from the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395) to address barriers to enrolling patients in precision medicine clinical trials for acute myeloid leukemia (AML). The key objectives are to: 1) develop rapid in-house molecular testing capabilities to enable broader patient access to precision medicine trials, and 2) conduct community and patient...
- The National Cancer Institute (NCI) awarded a $191,490 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) for the project "Implementing Pathways to Identify and Address Employment Concerns Among People with Cancer Across Diverse Clinical Settings." The overall objective is to identify and refer cancer patients with employment concerns to existing support resources through implementation and...
- The University of Kansas Medical Center Research Institute, Inc. (KUMCRI) received a $27,720,000 Project Grant award from the National Institute of Standards and Technology (NIST) under the Congressionally-Identified Projects (CFDA 11.617) program. The funding will support construction of a 33,000 square foot research wing for the University of Kansas Cancer Center, which recently earned the prestigious NCI Comprehensive Cancer Center designation. The new facility will house basic science,...
- The University of Colorado Cancer Center (UCCC) has been awarded a $547,080 Project Grant from the National Cancer Institute (CFDA 93.395 Cancer Treatment Research) to advance cancer screening and prevention trials. The grant aims to increase patient accrual and diversity in clinical trials, with a focus on expanding the number of National Clinical Trials Network (NCTN) trials and launching a new cancer prevention and survivorship modality team within the UCCC's Cancer Clinic Trials Office....
- The National Cancer Institute awarded a $197,747 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to the University of North Carolina at Chapel Hill. The grant, titled "IMPROVING AFFORDABILITY IN CANCER CARE THROUGH ECONOMIC SCREENING AND SUPPORT (I-ACCESS)", aims to pilot and refine a screening assessment and referral program to proactively identify cancer-related financial hardship in patients and connect them with financial education, counseling, and resources....
- The National Cancer Institute (NCI) awarded a $361,695 Project Grant under the Cancer Treatment Research program (CFDA 93.395) to the University of Oklahoma Health Sciences Center (OUHSC) for the period of September 1, 2025 to August 31, 2029. The grant aims to: 1) Leverage novel mHealth applications to boost enrollment in NCI-sponsored clinical trials, 2) Promote representative clinical trial enrollment from the local catchment area population, 3) Expand Veteran access to NCI trials, and 4)...
- This federal Project Grant award, funded by the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395), supports efforts by a Columbia University researcher to develop and implement NCI-sponsored cancer clinical trials at the NCI-designated Herbert Irving Comprehensive Cancer Center (HICCC). The $193,926 award, with a project period from September 1, 2025 to August 31, 2030, will enable the researcher to: (1) develop novel HICCC investigator-led trials for...
- The National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, awarded a $1,338,648 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to the University of Pittsburgh. The grant will fund a "Hybrid Type I Cluster Randomized Effectiveness-Implementation Trial of CARES" to address clinically significant levels of depression, pain, and fatigue experienced by over 18 million Americans living with cancer. The project aims to...
- This $575,051 Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) will support the University of Arizona Cancer Center (UACC) in enhancing its NCI-funded clinical research enterprise over a 5-year period from September 1, 2025 to August 31, 2030. The key objectives are to grow the breadth of the UACC's clinical trial portfolio to better serve its diverse patient population, increase accruals to interventional treatment trials (especially NCI-sponsored...
- This $620,000 Project Grant, awarded on June 15, 2024 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) to elucidate the late effects of radiation in head and neck cancer patients. The research aims to advance scientific knowledge and develop innovative therapies in the field of cancer. As a prime federal grant recipient, KUMCRI has an extensive...